Skip to main content
. 2015 Aug 1;8(8):9010–9020.

Figure 3.

Figure 3

Induction of apoptosis by gefitinib and celecoxib in NSCLC cell lines. A549 and HCC827 cells were treated with gefitinib (40 μmol/L), celecoxib (80 μmol/L) individually and in combination. Flow cytometry revealed significant differences (P ≤ 0.05) when the combination treatment and each single treatment were compared with the control.